Type I polyketide synthases (PKSs) are large multi-domain proteins converting simple acyl-CoA thioesters such as acetyl-CoA and malonyl
Introduction
In microorganisms and plants, polyketide synthases (PKSs) synthesize a broad range of chemically diverse secondary metabolites, including aromatics, macrolides, polyenes, and polyethers (Shen, 2003) . Due to their potent bioactivities, e.g. as antibiotics or antioxidants, polyketide-derived products are of interest for the development of pharmaceuticals or nutraceuticals (Kallscheuer et al., 2019; Shi et al., 2018; Yin et al., 2015) . In bacteria, PKSs are typically involved in the synthesis of antibiotics or secondary lipids, whereas in plants PKSs are essential for the production of polyphenols such as stilbenes and flavonoids (Schröder, 1997) .
As a common feature, PKSs catalyze the condensation of coenzyme A (CoA)-activated starter units and, in most cases, consume 3-12 malonyl-CoA molecules as building blocks during repetitive chain elongation reactions (Abe and Morita, 2010; Hertweck, 2009; Ray and Moore, 2016; Shen, 2003) . This assembly process is often accompanied by defined β-keto processing reactions. The resulting intermediate is subsequently folded into the final product by an intrinsic cyclase activity of the PKS or, alternatively, subject to hydrolysis or lactonization. Once released from the PKS, the polyketide can be further modified by decorating enzymes such as methyltransferases or glycosyltransferases or it serves as a starter molecule for the synthesis of more complex compounds (Schmidlin et al., 2008; Wang et al., 2014) . The architecture of PKSs is reflected by the presence of different catalytically active domains responsible for substrate selection, chain elongation, reductive processing and product release. Of particular interest are iterative type I PKSs, in which the catalytically active domains are combined in a single polypeptide chain. These domains bear acyltransferase (AT), ketosynthase (KS), ketoreductase (KR), dehydratase (DH), enoylreductase (ER) and thioesterase (TE) activities (Cox, 2007; Kage et al., 2015) . During polyketide synthesis, the growing carbon chain is bound to an acyl carrier protein (ACP) domain, which must have undergone a post-translational modification to provide an active thiol group for the required thioesterification (Hertweck, 2009) . This activation step is catalyzed by discrete 4'-phosphopantetheinyl transferases (PPTases), which transfer a 4'-phosphopantetheine residue from CoA to a conserved serine residue in the ACP domain, thereby converting the inactive apo form of the PKS to the active holo-PKS (Lambalot et al., 1996) .
In recent years, an increasing interest in using PKSs for the production of high value compounds in heterologous microorganisms arose. However, functional expression of genes coding for type I PKSs in such hosts is challenging (Yuzawa et al., 2012) . In particular, correct folding of PKS enzymes characterized by a typical length ranging from 1,500 to 4,000 amino acids and post-translational phosphopantetheinylation were identified as key issues.
Nevertheless, functional introduction of several PKSs was achieved e.g. in Escherichia coli and Streptomyces spp. by using strategies for improved protein folding and by co-expression of PPTase-encoding genes (Baltz, 2010; Liu et al., 2015; Ugai et al., 2015) .
Since decades, Corynebacterium glutamicum is used at industrial scale for the production of amino acids, in particular of L-glutamate and L-lysine (Eggeling and Bott, 2015) , but this bacterium was also engineered for the synthesis of other biotechnologically interesting compounds, e.g. alcohols, diamines, dicarboxylic acids, aromatic compounds and secondary metabolites (Heider et al., 2014; Kallscheuer and Marienhagen, 2018; Kallscheuer et al., 2016a; Litsanov et al., 2012; Nguyen et al., 2015; Vogt et al., 2016) . In previous studies, we already established the functional introduction of plant-derived type III PKSs with a typically length of 300-400 amino acids into C. glutamicum, which enabled plant polyphenol synthesis with this bacterium (Kallscheuer et al., 2016b; Milke et al., 2019b) .
In this study, we introduce C. glutamicum as a promising microbial host for polyketide production as we could functionally introduce the type I PKS 6-methylsalicylic acid synthase ChlB1 from Streptomyces antibioticus (ChlB1Sa, 1,756 aa, 186 kDa, UniProt ID Q0R4P8) into this bacterium Shao et al., 2006) . ChlB1Sa catalyzes the conversion of the starter unit acetyl-CoA and three molecules of malonyl-CoA into the aromatic compound 6-methylsalicylic acid (6-MSA) ( Fig. 1) (Parascandolo et al., 2016) . The latter is an important building block in the biosynthesis of several antibiotics, including chlorothricin, maduropeptin, pactamycin, and polyketomycin (Daum et al., 2009; Ito et al., 2009; Jia et al., 2006; Van Lanen et al., 2007) .
Material and methods

Bacterial strains, plasmids, media and growth conditions
All bacterial strains and plasmids used in this study and their relevant characteristics are listed in Table 1 . C. glutamicum was routinely cultivated aerobically at 30 °C in brain heart infusion (BHI) medium (Difco Laboratories, Detroit, USA) or in defined CGXII medium with 4 % (w/v) glucose as sole carbon and energy source (Keilhauer et al., 1993) . E. coli DH5α used for plasmid constructions was cultivated in LB medium (Bertani, 1951) at 37 °C. For maintenance of plasmids, kanamycin (50 µg/mL for E. coli or 25 µg/mL for C. glutamicum), chloramphenicol (25 μg/mL for E. coli) or spectinomycin (100 µg/mL for E. coli and C. glutamicum) was added to the medium. Bacterial growth was followed by measuring the optical density at 600 nm (OD600). C. glutamicum was grown for 6-8 hours in test tubes with 5 mL BHI medium on a rotary shaker at 170 rpm (first preculture) and was subsequently inoculated into 50 mL defined CGXII medium with 4 % (w/v) glucose in 500 mL baffled Erlenmeyer flasks (second preculture). Cell suspensions were cultivated overnight on a rotary shaker at 130 rpm. The main culture was inoculated to an OD600 of 5 in defined CGXII medium with 4 % (w/v) glucose and heterologous gene expression was induced one hour after inoculation using the indicated amount of IPTG.
Construction of plasmids and strains
Plasmids and strains used in this study are listed in table 1. Standard protocols of molecular cloning, such as PCR, DNA restriction, and ligation (Sambrook and Russell, 2001) , were carried out for recombinant DNA work. Techniques specific for C. glutamicum, e.g. electroporation for transformation of strains, were performed as described previously (Eggeling and Bott, 2005) . Synthetic genes were obtained from Thermo Fisher Scientific, formerly GeneArt (Darmstadt, Germany). Genes were amplified by PCR using oligonucleotides with unique restriction sites for cloning (Table 2 ). All constructed plasmids were finally verified by DNA sequencing at Eurofins Genomics (Ebersberg, Germany). The PPTase gene entD in E. coli BW25113 was inactivated by λ/Red recombineering (Datsenko and Wanner, 2000) . For this purpose, the ampicillin resistance gene from pUC19 was furnished with entD homologous arms by PCR using oligonucleotides entD-s and entD-as. The 1.3 kb-sized amplicon was introduced into E. coli BW25113/pIJ790 by electroporation after induction of λ red genes following a previously reported procedure (Kreutzer et al., 2011) .
The resulting transformants were incubated overnight at 37 °C on LB agar containing ampicillin (50 μg/mL). To identify recombinants with the desired mutation, PCRs using oligonucelotides entDSQ-s and entDSQ-as were conducted. The mutation in E. coli BW25113 entD::amp r was confirmed by DNA sequencing.
LC-MS analysis for quantification of 6-MSA in culture supernatants
6-MSA was quantified in culture supernatants by LC-MS using an Agilent ultra-highperformance LC 1290 Infinity System coupled to a 6130 Quadrupole LC-MS System (Waldbronn, Germany). LC separation was carried out using a Kinetex 1.7u C18 100 Å pore size column (50 mm by 2.1 mm (internal diameter)) (Phenomenex, Torrance, CA, USA) at 50 °C. For elution, 0.1 % (v/v) acetic acid (solvent A) and acetonitrile supplemented with 0.1 % (v/v) acetic acid (solvent B) were applied as the mobile phases at a flow rate of 0.3 mL/min. A gradient was used, where the amount of solvent B was increased stepwise: minute 0 to 6: 5 % to 30 %, minute 6 to 7: 30 % to 50 %, minute 7 to 8: 50 % to 100 % and minute 8 to 8.5: 100 % to 5 %. The mass spectrometer was operated in the negative electrospray ionization (ESI) mode, and data acquisition was performed in selected-ion-monitoring (SIM) mode.
Authentic metabolite standards were purchased from Thermo Fisher Scientific, formerly Acros
Chemicals (Geel, Belgium). Area values for [M-H]
-mass signals were linear up to metabolite concentrations of at least 250 mg/L. Benzoic acid (final concentration 100 mg/L) was used as internal standard. Calibration curves were calculated based on analyte/internal standard ratios for the obtained area values.
PPTase complementation in an entD-deficient E. coli variant
The promiscuity of PptACg was tested through the restoration of enterobactin biosynthesis by complementing the inactivated entD gene. For this, E. coli BW25113 entD::amp r was transformed either with the empty vector pEKEx3 or with the vector pEKEx3_pptACg harboring the pptACg gene from C. glutamicum. For analysis of enterobactin production, the two resulting E. coli strains were cultivated in 50 mL M9 mineral medium without iron supplementation at 37 °C to an OD600 of 0.6. At this time, expression of the pptACg gene was induced with 1 mM IPTG. Afterwards, the incubation was continued overnight at 37
°C. To verify the production of enterobactin, the cultures were acidified with hydrochloric acid (pH 2) and exhaustively extracted with ethyl acetate. After removal of the organic solvent, the crude extracts were dissolved in methanol. The extracts were analyzed by HPLC-MS using an Agilent 1260 Infinity System (Agilent, Waldbronn, Germany) coupled to a Bruker Compact ESI-Q-TOF mass spectrometer (Bruker, Bremen, Germany) equipped with a Nucleoshell RP-C18 column (100 mm x 2 mm, 2.7 µm, Macherey Nagel, Düren, Germany). A linear gradient of acetonitrile in water with 0.1 % (v/v) formic acid (from 5% to 98% acetonitrile within 10 min; flow rate, 0.4 mL/min) was used for metabolic profiling. UV chromatograms were recorded at 316 nm.
Results
Functional introduction of chlB1Sa into C. glutamicum enables 6-MSA synthesis
In the course of developing a C. glutamicum platform strain for plant polyphenol synthesis, the central carbon metabolism was reengineered towards increased availability of the PKS substrates acetyl-CoA and malonyl-CoA, and the entire catabolic network for aromatic compounds was eliminated to avoid any product degradation (Kallscheuer et al., 2016b; Milke et al., 2019a; Milke et al., 2019b For heterologous expression of the 6-MSA synthase gene from S. antibioticus, the codon-optimized chlB1Sa gene was cloned into the expression plasmid pMKEx2, which allows for an IPTG-inducible gene expression under the control of the strong T7 promoter (Kortmann et al., 2015) . In addition, a gene coding for the broad-spectrum PPTase Svp from
Streptomyces verticillus (SvpSv, UniProt ID Q9F0Q6) was co-expressed from the plasmid pEKEx3_svpSv for phosphopantetheinylation of ChlB1Sa (Sánchez et al., 2001) . Unfortunately, the constructed strain C. glutamicum DelAro 4 C5 mufasOBCD1 pMKEx2_chlB1Sa pEKEx3_svpSv failed to produce any LC-MS-detectable amounts of 6-MSA when cultivated in defined CGXII medium with 4 % (w/v) glucose and two different IPTG concentrations (20 µM or 1 mM).
However, problems related to folding of "challenging" proteins such as ChlB1Sa were not unexpected when considering its protein size of 186 kDa. Thus, we decided to test translational fusion of ChlB1Sa to the C-terminus of the maltose binding protein MalE of E. coli.
Although being even larger than ChlB1Sa (1,756 aa, 186 kDa), the MalEEc-ChlB1Sa fusion protein (2,139 aa, 228 kDa) appeared to be active in C. glutamicum as accumulation of 2 mg/L (0.013 mM) and 6 mg/L 6-MSA (0.039 mM) after induction with 20 µM or 1 mM IPTG, respectively, could be detected (Fig. 3a,b) . Neither under non-inducing conditions (no IPTG) nor in case of cultivation of a control strain harboring only the two empty plasmids, 6-MSA synthesis could be observed. were tested in cultivations of the engineered C. glutamicum strain (Fig. 4) . These experiments revealed, that limited Mg 2+ availability was indeed the reason for the observed reducedgrowth-phenotype since all cultures with MgSO4 concentrations > 1 mM reached a final OD600 between 50 to 55, typical for shake flask cultivations of C. glutamicum. In this context, it was not surprising that low Mg 2+ concentrations also limited 6-MSA synthesis as cultivations with 15 mM MgSO4 doubled product titers, reaching 14 mg/L (0.09 mM) 6-MSA. The highest product titer of 20 mg/L (0.13 mM) at this stage was determined in cultivations with supplementation of 50 mM MgSO4, whereas supplementation of 100 mM MgSO4 and above had a negative effect on product formation (Fig. 3) . All subsequent cultivations for 6-MSA production were thus performed in defined CGXII medium containing 50 mM MgSO4.
An endogenous PPTase of C. glutamicum can activate ChlB1Sa
In microbial host systems engineered for polyketide synthesis involving type I PKS, PPTase-mediated PKS activation is essential for product formation, but not every PPTase is capable of activating every PKS (Cox et al., 1997; Shen et al., 1992) . The PPTase SvpSv from S. verticillus was initially selected due to its well-described ability to activate a broad range of different type I PKSs and the close relationship of S. verticillus to S. antibioticus, from which ChlB1Sa originates (Sánchez et al., 2001) . With the aim to identify an even more suitable
PPTase for ChlB1Sa activation in C. glutamicum, we evaluated the performance of other broadspectrum PPTases such as SfpBs (UniProt ID P39135) from Bacillus subtilis and NpgAAn (UniProt ID G5EB87) from Aspergillus nidulans (Oberegger et al., 2003; Quadri et al., 1998 identified two genes encoding PPTases, namely pptA (cg2171) and acpS (cg2738). AcpSCg (UniProt ID Q8NMS4) was shown to be crucial for the activation of the fatty acid synthases FasI-A and FasI-B in this bacterium (Chalut et al., 2006) . The putative function of PptACg (UniProt ID Q8NP45) is the activation of the sole type I PKS13 in C. glutamicum (Cg3178, 1610 aa, 172 kDa), which is required for the synthesis of corynomycolic acids as important building blocks for cell wall synthesis in coryneform bacteria (Gande et al., 2004) .
Motivated by the finding that an endogenous PPTase of C. glutamicum is capable of activating ChlB1Sa, we compared the sequence of the two endogenous PPTase candidates PptACg and AcpSCg to SvpSv. PptACg and SvpSv share a sequence identity of 34 % (sequence similarity: 58 %), whereas AcpSCg appears to be unrelated to SvpSv (sequence identity: 8 %;
sequence similarity: 19 %) (Fig. S1 ). Hence, it appears to be more likely that PptACg rather than AcpSCg can activate ChlB1Sa in C. glutamicum. This notion is also supported by the domain architecture as both enzymes, PptACg and SvpSv, belong to the EntD superfamily of PPTases (NCBI domain cl27525), whereas AcpSCg is a PPTase of the ACPS superfamily (NCBI domain cl00500). In order to confirm the relevance of PptACg for ChlB1Sa activation, deletion of the respective gene pptA was planned, However, a pptA deletion mutant was previously shown to exhibit a severe growth phenotype reflected in cell aggregation during cultivation in liquid medium (Chalut et al., 2006) . For this reason, the idea of deleting pptA was abandoned as discrimination between lacking 6-MSA production due to missing PptACgmediated ChlB1Sa-activation or poor growth is not possible. Instead, it was tested whether overexpression of pptA could further improve 6-MSA production with C. glutamicum. The strain C. glutamicum DelAro 4 C5 mufasOBCD1 pMKEx2_malEEc-chlB1Sa pEKEx3_pptACg accumulated only 18 mg/L (0.12 mM) 6-MSA, which further supports the notion that reduced 6-MSA titers in the strains additionally expressing PPTase-encoding genes are due to an increased metabolic burden and that the native pptACg expression is already sufficient for ChlB1Sa activation.
PptA of C. glutamicum is a broad-spectrum PPTase
To interrogate a possible broad-spectrum PPTase activity of PptACg, further experiments were performed in E. coli. This bacterium is in general capable of producing the catecholate siderophore enterobactin under iron-limited conditions (Grass, 2006) .
Biosynthesis of enterobactin involves six proteins of which two, EntB and EntF, feature carrier protein domains (Gehring et al., 1998) . Analogous to PKS systems, both EntB and EntF are phosphopantetheinylated by a PPTase named EntD (UniProt ID P19925) encoded in the enterobactin locus (Gehring et al., 1997; Lambalot et al., 1996) . While inactivation of entD abolishes production of enterobactin in E. coli (Cox et al., 1970) , this phenotype can be rescued by complementation with an exogenous PPTase (Barekzi et al., 2004) . To test whether PptACg is similarly capable to act as a substitute for the enterobactin PPTase, an entD mutation was introduced into the E. coli strain BW25113, which was previously reported as enterobactin producer (Ma and Payne, 2012) . Comparative LC-MS analyses with the wild type confirmed the loss of enterobactin in the E. coli BW25113 entD::amp r strain (data not shown).
Hence, it was evident that E. coli BW25113 does not possess another PPTase, which could compensate for the functional loss of EntD. Following the expression of pptACg in E. coli BW25113 entD::amp r , the mutant resumed the production of enterobactin, which strongly suggests that PptACg is capable to phosphopantetheinylate the two carrier protein domains in EntB and EntF (Fig. 3c) . This experiment indicates that PptACg of C. glutamicum can indeed activate various carrier protein domains and can thus be regarded as broad-spectrum PPTase with many possible applications in microbial natural product synthesis.
Discussion
Iterative type I PKSs biocatalysts are particularly appealing for the production of highvalue molecules from simple CoA-activated precursors derived from the central carbon metabolism. Once an iterative PKS is activated, all reaction steps are catalyzed by individual domains, in that sense the PKS itself represents a biochemical "assembly line" within a microbial cell factory. This avoids to a large degree any engineered deregulation of natural biosynthetic pathways and thereby circumvents the accumulation of undesired side-products.
In consequence, iterative PKSs can be considered as ideal targets for the production of chemical building blocks as well as medicinal drugs in engineered microbial cell factories.
Here, we functionally integrated the 6-MSA synthase ChlB1 from S. antibioticus into C.
glutamicum and demonstrated its suitability as a cell factory for 6-MSA synthesis. Production of related hydroxybenzoic acids in engineered microorganism such as salicylic acid (a derivative of 6-MSA lacking the methyl group) requires deregulation and engineering of the shikimate pathway and can lead to metabolic imbalances, auxotrophic strains or undesired accumulation of side products (Kallscheuer and Marienhagen, 2018; Lin et al., 2014) . In contrast, after introduction of ChlB1 Sa in C. glutamicum no significant accumulation of side products could be observed.
Microbial production of 6-MSA using the 6-MSA synthase from Penicillium patulum was already demonstrated earlier using E. coli and Saccharomyces cerevisiae as production hosts (Kealey et al., 1998; Wattanachaisaereekul et al., 2007; Wattanachaisaereekul et al., 2008) . For the essential PPTase-mediated activation of the heterologous PKS, co-expression of a broad spectrum PPTase gene, such as sfp from B. subtilis, was mandatory in both hosts.
In the direct comparison, S. cerevisiae was more suitable for 6-MSA production as titers from 0.2-1.7 g/L (1.3-11.2 mM) 6-MSA were reported, whereas E. coli accumulated only 75 mg/L (0.49 mM) (Kealey et al., 1998; Wattanachaisaereekul et al., 2008) . The determined product concentrations in E. coli are comparable to 6-MSA titers obtained using engineered
Streptomyces coelicolor strains (Bedford et al., 1995) and with C. glutamicum in this study.
The performance of the different production hosts, however, is difficult to compare as we decided to use ChlB1 from S. antibioticus in this study instead of the enzyme from P. patulum.
In both organisms, C. glutamicum and E. coli, challenges related to protein insolubility needed to be addressed. In our study improved folding was achieved by translation fusion of the PKS to the maltose-binding protein MalE, whereas co-expression of chaperone-encoding genes from S. coelicolor improved folding and solubility of different type I PKSs in E. coli (Betancor et al., 2008) . In case of the essential PPTase-mediated activation of PKSs, we could show that C. glutamicum harbors a broad-spectrum PPTase (PptA Cg), which is not only capable of activating ChlB1Sa, but also activates the enterobactin biosynthesis enzymes EntB and EntF in E. coli. It is thus likely that expression of a heterologous PPTase gene can be omitted in future PKS-and NRPS-related applications using C. glutamicum, which will significantly simplify and shorten strain development times as only the core biosynthesis gene needs to be functionally expressed. This important property of C. glutamicum cannot be valued highly enough as phosphopantetheinylation in heterologous hosts often fails due to the inavailability of a suitable PPTase (Crosby et al., 1995; Li and Neubauer, 2014; Roberts et al., 1993; Shen et al., 1992) .
Taken together, we consider C. glutamicum as a promising host organism for microbial polyketide production using type I PKSs. C. glutamicum is an actinomycete and thus closely related to Streptomycetes, which are a valuable source of many interesting type I PKSs (including ChlB1Sa). Access to C. glutamicum variants with increased acetyl-CoA and malonylCoA availability and easy-to-handle production plasmids enabling the expression of soluble MalE-fusion proteins further underline the potential of this microorganism for polyketide synthesis. Relevant restriction sites are underlined; SapI cuts outside of its recognition site; the obtained 5'-overhangs after SapI cleavage used for Electra Cloning are shown in bold. Due to the presence of internal restriction sites, the npgAAn gene was cloned using Gibson assembly. 
